We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRX
9376
DELISTED
Chimerix, Inc.
CMRX
$64K ﹤0.01%
+10,292
New +$70.8K
PMVC.WS
9377
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$64K ﹤0.01%
102,800
+2,700
+3% +$2.08K
GSS
9378
DELISTED
Golden Star Resources Ltd.
GSS
$64K ﹤0.01%
27,075
-28,817
-52% -$69.2K
CEMI
9379
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$64K ﹤0.01%
+25,500
New +$70.7K
MCF
9380
PUT
DELISTED
Contango Oil & Gas Co.
MCF
$64K ﹤0.01%
14,100
-500
-3% -$1.9K
RESN
9381
CALL
DELISTED
Resonant Inc.
RESN
$63K ﹤0.01%
26,100
-4,200
-14% -$11.6K
KCAC.WS
9382
DELISTED
Kensington Capital Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one
KCAC.WS
$63K ﹤0.01%
+55,476
New +$73.5K
APRE icon
9383
PUT
Aprea Therapeutics
APRE
$8.05M
$62K ﹤0.01%
+605
New +$55K
GOAC.WS
9384
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$62K ﹤0.01%
84,842
-6,765
-7% -$6.11K
ALIT.WS
9385
DELISTED
Alight Inc Warrants
ALIT.WS
$62K ﹤0.01%
+20,454
New +$51K
CRNT icon
9386
Ceragon Networks
CRNT
$201M
$61K ﹤0.01%
17,465
-96,130
-85% -$363K
KALA icon
9387
PUT
KALA BIO
KALA
$14.5M
$61K ﹤0.01%
9
-6
-40% -$51.8K
BURU.WS
9388
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$61K ﹤0.01%
105,661
+3,561
+3% +$3.16K
PRPC.WS
9389
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$61K ﹤0.01%
60,758
+386
+0.6% +$458
OIIM
9390
DELISTED
02Micro International
OIIM
$61K ﹤0.01%
+10,023
New +$67.2K
BKEP
9391
DELISTED
Blueknight Energy Partners L.P.
BKEP
$61K ﹤0.01%
20,093
ADVM
9392
PUT
DELISTED
Adverum Biotechnologies
ADVM
$60K ﹤0.01%
2,760
+1,020
+59% +$26K
CPRX
9393
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$60K ﹤0.01%
11,300
-9,300
-45% -$50.9K
HOOK
9394
PUT
DELISTED
HOOKIPA Pharma
HOOK
$60K ﹤0.01%
1,020
-270
-21% -$19.6K
VVOS icon
9395
Vivos Therapeutics
VVOS
$4.5M
$60K ﹤0.01%
+600
New +$63.1K
CANO.WS
9396
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$60K ﹤0.01%
14,480
+4,150
+40% +$15.6K
YSAC.WS
9397
DELISTED
Yellowstone Acquisition Company Warrants, each whole warrant exercisable for one share of Class A co
YSAC.WS
$60K ﹤0.01%
63,387
-2,211
-3% -$1.88K
OLB icon
9398
OLB
OLB
$4.49M
$59K ﹤0.01%
+1,470
New +$75.6K
TRUE
9399
DELISTED
TrueCar
TRUE
$59K ﹤0.01%
14,269
-69,914
-83% -$324K
VIOT
9400
Viomi Technology
VIOT
$49.2M
$59K ﹤0.01%
+12,948
New +$72.9K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.